Follow The Filings

PRVA Privia Health Group

Privia Health Group earnings company data as of 12:01 PM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS 0.09 — —
Rev — — —

Insider trades

Open-market buys and sales by PRVA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All PRVA insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $16.1M sold by 3 insiders under 10b5-1 plans
  1. David Mountcastle CFO
    Planned sale
    $589K 21,275 shares at $27.67 11% of stake
    Traded Jul 9 Filed Jul 13
    ↗
  2. David Mountcastle CFO
    Planned sale
    $17K 600 shares at $27.57 0.3% of stake
    Traded Jul 7 Filed Jul 9
    ↗
  3. David Mountcastle CFO
    Planned sale
    $680K 24,734 shares at $27.50 12% of stake
    Traded Jul 2 Filed Jul 7
    ↗
  4. Matthew Shawn Morris Director
    Planned sale
    $3.1M 112,759 shares at $27.29 62% of stake
    Traded Jul 2–6 Filed Jul 7
    ↗
  5. Matthew Shawn Morris Director
    Planned sale
    $3.6M 135,498 shares at $26.32 64% of stake
    Traded Jun 30–Jul 1 Filed Jul 2
    ↗
  6. Matthew Shawn Morris Director
    Planned sale
    $3.8M 151,322 shares at $25.33 66% of stake
    Traded Jun 26–29 Filed Jun 30
    ↗
  7. David Mountcastle CFO
    Planned sale
    $433K 17,196 shares at $25.18 7.5% of stake
    Traded Jun 26 Filed Jun 30
    ↗
  8. Parth Mehrotra CEO
    Planned sale
    $354K 15,647 shares at $22.64 3.5% of stake
    Traded May 12 Filed May 13
    ↗
  9. David Mountcastle CFO
    Planned sale
    $210K 8,385 shares at $25.03 3.8% of stake
    Traded May 1–4 Filed May 5
    ↗
  10. Matthew Shawn Morris Director
    Planned sale
    $453K 18,113 shares at $24.99 21% of stake
    Traded May 1–4 Filed May 5
    ↗
  11. Parth Mehrotra CEO
    Planned sale
    $479K 21,097 shares at $22.71 6.1% of stake
    Traded Mar 10 Filed Mar 12
    ↗
  12. Parth Mehrotra CEO
    Planned sale
    $529K 23,134 shares at $22.87 6% of stake
    Traded Mar 9 Filed Mar 10
    ↗
  13. David Mountcastle CFO
    Planned sale
    $327K 13,058 shares at $25.03 7% of stake
    Traded Feb 26–27 Filed Mar 2
    ↗
  14. Matthew Shawn Morris Director
    Planned sale
    $608K 24,338 shares at $25.00 26% of stake
    Traded Feb 26–27 Filed Mar 2
    ↗
  15. David Mountcastle CFO
    Planned sale
    $598K 23,887 shares at $25.03 12% of stake
    Traded Dec 12, 2025 Filed Dec 16, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 17 option exercises, 15 sales to cover taxes, and 14 stock grants.

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13D — Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.